Collegium Pharmaceutical
COLL
COLL
75 hedge funds and large institutions have $273M invested in Collegium Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less capital invested
Capital invested by funds: $307M → $273M (-$33.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $506K
Holders
75
Holding in Top 10
1
Calls
–
Puts
$506K
Top Buyers
| 1 | +$8.64M | |
| 2 | +$5.18M | |
| 3 | +$2.25M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$2.22M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$2.22M |
Top Sellers
| 1 | -$4.95M | |
| 2 | -$2.75M | |
| 3 | -$2.08M | |
| 4 |
BCMNY
Buckingham Capital Management (New York)
New York
|
-$1.11M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$622K |